Actionnariat et activité des initiés pour Sutro Biopharma, Inc. (STRO): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $15.60 |
| Capitalisation | $151M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-06-05 | Wigginton Jon Marc | A-Award | 10,000 | $261K |
| 2026-06-05 | Petree Daniel H | A-Award | 10,000 | $261K |
| 2026-06-05 | PANEK JAMES P | A-Award | 10,000 | $261K |
| 2026-06-05 | Lobacki Joseph M | A-Award | 10,000 | $261K |
| 2026-06-05 | Jagpal Sukhi | A-Award | 10,000 | $261K |
| 2026-06-05 | Hunter Heidi | A-Award | 10,000 | $261K |
| 2026-06-05 | Dybbs Michael | A-Award | 10,000 | $261K |
| 2026-06-05 | MATSUI CONNIE | A-Award | 10,000 | $261K |
| 2026-06-02 | Chow Gregory K. | M-Exempt | 2,500 | |
| 2026-06-02 | Chow Gregory K. | M-Exempt | 2,500 |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $11.6M | $22.0M | $125.3M | $5.0M | $206.2M | $30.4M | $47.3M | $69.3M | $190.3M | $58.1M |
| Placements à Court Terme | $35.9M | 0 | $79.2M | $112.9M | $162.0M | $167.5M | $287.1M | $306.4M | $126.6M | $83.3M |
| Créances | $577000 | $1.6M | $2.5M | $6.3M | $5.6M | $12.5M | $7.1M | $36.1M | $8.6M | $4.0M |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $49.7M | $25.6M | $209.9M | $128.6M | $378.2M | $218.5M | $353.2M | $421.5M | $343.3M | $150.9M |
| Immobilisations Corporelles | $18.7M | $14.0M | $10.9M | $9.6M | $12.9M | $51.6M | $51.1M | $44.8M | $35.9M | $21.6M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $69.3M | $40.8M | $223.1M | $156.4M | $394.1M | $341.4M | $406.9M | $470.7M | $387.2M | $173.8M |
| Dettes Fournisseurs | $3.4M | $2.9M | $3.1M | $5.6M | $5.5M | $6.0M | $4.8M | $9.4M | $10.5M | $7.6M |
| Dette à Court Terme | 0 | $14.6M | $4.7M | $1.0M | 0 | $9.4M | $17.1M | $4.1M | 0 | 0 |
| Passifs Courants | $50.2M | $32.0M | $36.4M | $33.0M | $29.6M | $41.7M | $66.5M | $93.7M | $131.9M | $75.1M |
| Dette à Long Terme | 0 | 0 | $10.0M | $8.9M | $24.5M | $15.7M | $3.8M | 0 | 0 | 0 |
| Passifs Totaux | $160.2M | $149.8M | $91.6M | $58.6M | $62.1M | $88.8M | $189.9M | $321.1M | $342.6M | $306.3M |
| Réserves | -$95.3M | -$115.0M | -$150.3M | -$195.7M | -$227.9M | -$333.4M | -$452.6M | -$559.4M | -$786.9M | -$978.0M |
| Capitaux Propres | -$90.9M | -$109.0M | $131.5M | $97.8M | $332.0M | $252.6M | $217.0M | $149.6M | $44.6M | -$132.5M |
| Dette Totale | $1.2M | $14.6M | $14.7M | $9.9M | $24.5M | $57.4M | $55.0M | $33.6M | $23.2M | $15.7M |
| Dette Nette | -$46.3M | -$7.4M | -$189.8M | -$108.0M | -$343.6M | -$140.6M | -$279.3M | -$342.0M | -$293.7M | -$125.8M |
| Fonds de Roulement | -$493000 | -$6.3M | $173.5M | $95.6M | $348.6M | $176.8M | $286.6M | $327.8M | $211.4M | $75.8M |
Santé financière
| Dette / Capitaux propres | -0.10 |
| Ratio de liquidité | 3.32 |
Rentabilité
| Rentabilité des capitaux propres | 185.30% |
| Rentabilité du capital investi | -95.49% |
| Rentabilité des actifs | -92.89% |
| Marge brute | 97.20% |
| Marge opérationnelle | -309.87% |
| Marge nette | -395.25% |
Entreprises liées: ADVM · ARTV · CNTB · DTIL · GUTS · IFRX · KLRS
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de STRO: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions